2019
DOI: 10.1016/j.jagp.2018.10.019
|View full text |Cite
|
Sign up to set email alerts
|

Safety and Efficacy of Accelerated Repetitive Transcranial Magnetic Stimulation Protocol in Elderly Depressed Unipolar and Bipolar Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
34
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
4
2
1

Relationship

1
6

Authors

Journals

citations
Cited by 45 publications
(34 citation statements)
references
References 61 publications
0
34
0
Order By: Relevance
“…Indeed, it is supposed that cortical atrophy of the frontal lobe and higher rate of somatic symptoms are reasons for the fewer efficacy of rTMS in late-life depression [ 57 , 59 ]. Nevertheless, an accelerated rTMS protocol was shown to be more efficient in older depressed people (> 60 years) [ 60 ]. Recently, a trial with deep-rTMS provided promising results [ 61 ].…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, it is supposed that cortical atrophy of the frontal lobe and higher rate of somatic symptoms are reasons for the fewer efficacy of rTMS in late-life depression [ 57 , 59 ]. Nevertheless, an accelerated rTMS protocol was shown to be more efficient in older depressed people (> 60 years) [ 60 ]. Recently, a trial with deep-rTMS provided promising results [ 61 ].…”
Section: Discussionmentioning
confidence: 99%
“…Desbeaumes and colleagues 31 included, in their retrospective study, 19 older adults with LLD with a mean age of 71.0 years (SD 8.3) treated with HF‐rTMS at left DLPFC (20 Hz). Five older adults (26.3%) reported AE such as headaches, local sensitivity and fatigue.…”
Section: Resultsmentioning
confidence: 99%
“…A retrospective analysis on 30 twice‐daily sessions of 20‐Hz HFL for TRD compared the response rates of accelerated rTMS between young and older adults ( N = 73; n = 19 ≥60 years; n = 54 <60 years). The authors reported significant clinical improvements in both groups, with the ≥60 year group reporting greater improvement than the young subjects, with more responders and remitters among older subjects …”
Section: Cost‐effectiveness In Rtms For Mddmentioning
confidence: 93%
“…The authors reported significant clinical improvements in both groups, with the ≥60 year group reporting greater improvement than the young subjects, with more responders and remitters among older subjects. 53 A clinical trial examining accelerated rTMS (N = 58; HFL 3 times per day, 3 days in week 1, 3 treatments over 2 days in weeks 2 and 3 treatments on a single day in week 3) compared with daily rTMS (n = 57; 5 days per week for 4 weeks) found no significant differences in remission or response rates between the two groups. 54 In a retrospective study, treatment outcomes of 36 patients with MDD who received 30 sessions of 10-Hz HFL with either twicedaily (n = 17) or daily (n = 19) rTMS, the authors reported a trend toward greater response rate in the twice-daily group (82.4%) compared with the once-daily group (52.6%).…”
Section: Accelerated Protocols: Can Response and Remission Be Achievementioning
confidence: 99%